B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response

SARS-CoV-2 mRNA 第三次疫苗接种后的 B 细胞分析显示,出现了类似抗体反应的混合免疫反应。

阅读:2
作者:Emanuele Andreano # ,Ida Paciello # ,Giulio Pierleoni ,Giulia Piccini ,Valentina Abbiento ,Giada Antonelli ,Piero Pileri ,Noemi Manganaro ,Elisa Pantano ,Giuseppe Maccari ,Silvia Marchese ,Lorena Donnici ,Linda Benincasa ,Ginevra Giglioli ,Margherita Leonardi ,Concetta De Santi ,Massimiliano Fabbiani ,Ilaria Rancan ,Mario Tumbarello ,Francesca Montagnani ,Claudia Sala ,Duccio Medini ,Raffaele De Francesco ,Emanuele Montomoli ,Rino Rappuoli

Abstract

The continuous evolution of SARS-CoV-2 generated highly mutated variants able to escape natural and vaccine-induced primary immunity. The administration of a third mRNA vaccine dose induces a secondary response with increased protection. Here we investigate the longitudinal evolution of the neutralizing antibody response in four donors after three mRNA doses at single-cell level. We sorted 4100 spike protein specific memory B cells identifying 350 neutralizing antibodies. The third dose increases the antibody neutralization potency and breadth against all SARS-CoV-2 variants as observed with hybrid immunity. However, the B cell repertoire generating this response is different. The increases of neutralizing antibody responses is largely due to the expansion of B cell germlines poorly represented after two doses, and the reduction of germlines predominant after primary immunization. Our data show that different immunization regimens induce specific molecular signatures which should be considered while designing new vaccines and immunization strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。